Syk inhibitors

Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting
Sun Herald, MS
Sun, 12/5/10 - 12:16 pm
Portola Pharmaceuticals
non-Hodgkin's lymphoma
chronic lymphocytic leukemia
rheumatoid arthritis
JAK inhibitors
Syk inhibitors